The Food and Drug Administration hopes to boost the effectiveness of the influenza vaccine for this coming season, the Centers for Disease Control and Prevention reported.
The Centers for Disease Control and Prevention is advising clinicians to be on the lookout for a new bird flu.
The Federal Trade Commission plans to examine the advertising practices of the homeopathy industry.
GoJo joined 150 companies at the White House to advocate for antibiotic stewardship on Tuesday.
Appeals court forces Actavis to keep its Alzheimer's treatment Namenda IR on the market.
Acquisition target Perrigo recently filed a complaint to Irish Takeover Panel regarding Mylan proposal.
Specialized manufacturers are gearing up for a robust trade out of generic biosimilar approvals, Kalorama reported last week.
Aurobindo Pharma has submitted an abbreviated new drug application for dolutegravir 50 mg to the Food and Drug Administration for the treatment of HIV.
The Food and Drug Administration has approved Boehringer Ingelheim, Inc.'s Stiolto Respimat (tiotropium bromide and olodaterol), a once-daily inhaler meant to treat obstructed airflow in patients, the company announced Tuesday.
The United Kingdom's Competition and Markets Authority feels that Reckitt-Benckiser acquisition of K-Y personal lubricants may lead to higher prices across the category.